Back to Freepaper Session

Evaluation of an aberration-corrected, pure diffractive multifocal IOL (MIOL) as a toric and non-toric version

Session Details

Session Title: Multifocal IOL results

Session Date/Time: Sunday 06/10/2013 | 14:30-16:00

Paper Time: 14:51

Venue: Forum (Ground Floor)

First Author: : F.Kretz GERMANY

Co Author(s): :    A. Fitting   I. Limberger   G. Auffarth        

Abstract Details

Purpose:

Clinical evaluation of an aberration corrected, pure diffractive MIOL in a toric and a non-toric version.

Setting:

International Vision Correctio and Research Centre (IVCRC), Dept. of Ophthalmology, University Hospital Heidelberg

Methods:

For cataract surgery we implanted a non-toric MIOL (ZMB00, AMO, USA) in patients with a corneal astigmatism of less than 1 [D] or a toric MIOL (ZMT--, AMO, USA) in patients with an astigmatism over 1 [D]. Surgical induced astigmatism was taken in account for the corneal astigmatism. Both models contain a near addition of +4.0 [D]. Pre-operative biometry was performed with the IOL-Master (V5.4, Carl Zeiss Meditech, Germany). Subjective refraction, corrected and uncorrected visual acuity, monocular and binocular (near in 30cm and distance [logMar]) as well as a binocular defocus curve were evaluated.

Results:

One week after surgery monocular UDVA was 0.1 in both MIOL groups with an UNVA of 0.2 in the toric and 0.1 in the non-toric MIOL group [logMAR]. Patients with a toric MIOL and a non-toric MIOL in the othe eye even reached a UNVA of -0.05.

Conclusions:

The aberration corrected, pure diffractive multifocal IOL with and without astigmatism correction show good refractive results for near and distance visual acuity. The patient satisfaction is very high.

Financial Interest:

... receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, ... travel has been funded, fully or partially, by a competing company, ... travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, ... research is funded, fully or partially, by a competing company, ... research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, ... receives consulting fees, retainer, or contract payments from a competing company